By Ms Helen Monaghan

Conference Abstracts

Lin FP; McKay S; Zaheed M; Douglas B; Ke H; Koh B; Liang S; Morrow A; Chan J; Chua B; Kennedy E; Leaney K; Monaghan H; Middleton S; Ballinger ML; Thomas DM; Parkinson B; Tucker K; Goldstein D; Taylor N, 2025, '781P Impact of a quaternary genomics multidisciplinary team (MDT) on oncological decision-making: Pilot phase of the UNSW precision care initiative (PCI)', in Annals of Oncology, Elsevier, Vol. 36, pp. s1991 - s1992, http://dx.doi.org/10.1016/j.annonc.2025.10.1195

Canney M; Shan S; Er L; Billot L; Han J; Wong MG; Monaghan H; Cattran DC; Barbour S, 2025, 'Predicting individual patient response to corticosteroids in IgA nephropathy: a secondary analysis from the TESTING cohort', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, Vol. 40, http://dx.doi.org/10.1093/ndt/gfaf116.0199

Kim D; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Billot L; Zhang H; Perkovic V; Wong MG, 2022, 'EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISONE IN IGA NEPHROPATHY: THE TESTING TRIAL', in NEPHROLOGY, WILEY, Vol. 27, pp. 14 - 14

Preprints

Billot L; Coggan S; Fan L; Perkovic V; Yu XQ; Badve SV; Jardine M; Ning T; Chen W; Monaghan H; Chen M; He Z; Ma G; Kotwal S; Wong MG, 2026, Statistical Analysis Plan for the Aspiring to Reduce Events in Dialysis Trial (ASPIRED), http://dx.doi.org/10.64898/2026.01.12.26343774

Billot L; Monaghan H; Wong MG; Perkovic V, Statistical Analysis Plan for the Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING), http://dx.doi.org/10.31219/osf.io/d7qrw

Back to profile page